VBVictoria E. Banuchi

Victoria E. Banuchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Victoria E. Banuchi has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterization of Advanced RAS -driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues

    by Sarah Hamidi, Anastasios Maniakas, Neal S Akhave, Victoria E Banuchi, Naifa L Busaidy, Ramona Dadu, Renata Ferrarotto, Theresa A Guise, Marie-Claude Hofmann, S Mohsen Hosseini, et al.

    Context: With novel RAS-targeted therapies emerging, better understanding of RAS-driven differentiated (DTC) and anaplastic (ATC) thyroid cancers is warranted. Objective: Characterize the genotypic and phenotypic landscape of RAS-driven DTC and ATC and review current and future therapeutic avenues. Design: Retrospective chart review between January 2015 and June 2023. Median follow-up duration 8.4 years in DTC cohort and 36.4 months in ATC cohort. Setting: Single-center study at MD Anderson Cancer Center. Patients: Individuals with RAS-altered DTC or ATC identified before kinase inhibitor exposure. Interventions: None. Main Outcome Measures: Primary objective was to describe clinical and molecular characteristics. Secondary objectives included identifying prognostic factors and assessing survival outcomes with available therapies. Results: Among 120 RAS-driven DTC and 71 RAS-driven ATC, NRAS was the most common alteration (69% of DTC, 70% of ATC), mainly at residue Q61. Brain metastases were found in 22% of patients undergoing brain imaging (19% in DTC, 25% in ATC). Median overall survival (OS) was 15.2 years in DTC, with 49% of patients receiving at least 1 line of systemic therapy, most commonly lenvatinib (66%). Median time to systemic therapy was 3.5 years from diagnosis, and median OS from therapy initiation was 6.0 years. In ATC, median OS was 7.5 months. Stage IVC [hazard ratio (HR) = 6.78)], neck surgery (HR = 0.29), and exposure to immunotherapy (HR = 0.13) were significantly associated with mortality. Conclusion: Advanced RAS-driven follicular-derived thyroid cancers seem to exhibit an aggressive behavior, particularly in ATC, in which prognosis remains poor despite expert multidisciplinary care. Advances in RAS-targeted therapies offer hope for improved therapeutic options.


  • The use of thyroid isthmusectomy for management of well differentiated thyroid carcinoma - A systematic review and meta-analysis

    by Moon Usman, Peter Yao, Kathleen Luckett, Katerina Andreadis, Remil Thomas, Andy Hickner, Paul J. Christos, Andrew Tassler, David Kutler, William Kuhel, et al.


  • Scarless Neck Feminization: Chondrolaryngoplasty Through Endoscopic Transoral Vestibular Approach

    by Victoria E. Banuchi, Samuel N. Helman

    We present in this paper a novel approach to perform endoscopic chondrolaryngoplasty without any external visible scars. The technique involves utilizing the endoscopic transoral vestibular approach. We have modified the technique by using the placement of a suture immediately above the anterior commissure, which provides a marker for the inferior extent of cartilage resection. Laryngoscope, 133:1099-1102, 2023.


  • Impingement of the Thyroid Cartilage on the Carotid Causing Clicking Larynx Syndrome and Stroke

    by Catherine Y. Han, Sallie M. Long, Neal S. Parikh, C. Douglas Phillips, Adetokunbo Obayemi, Victoria X. Yu, Victoria Banuchi

    We present the case of a patient with a recent history of ischemic stroke who presented with clicking larynx syndrome, a condition in which clicking noises in the larynx can be provoked by movement of the head and neck. Diagnostic imaging revealed unusual development and posterior angulation of the superior horn of the thyroid cartilage that potentially was causing trauma to the left common carotid artery. We deduced that symptomatic impingement of the carotid artery by the thyroid cartilage was not only the cause of the patient's clicking larynx syndrome, but also suspected to be the cause of her prior strokes due to repetitive trauma resulting in thrombus. The patient was managed surgically with thyroplasty and transcervical resection of the left greater cornu of the thyroid cartilage with resolution of her symptoms. Anatomical displacement of the thyroid cartilage can manifest as clicking larynx syndrome as well as cause mechanical injury to the carotid artery, resulting in turbulent flow, possible thrombosis, and stroke. Laryngoscope, 132:1410–1413, 2022


  • Airway injury from transoral endoscopic thyroidectomy vestibular approach

    by Sallie M. Long, Khalid Ali, Ralph P. Tufano, Victoria E. Banuchi

    Background: The transoral endoscopic thyroidectomy vestibular approach (TOETVA) is a novel technique that eliminates a cervical scar. This procedure carries unique risks, and data on outcomes are needed as more cases are performed.Methods: We describe two cases of airway injury during the TOETVA. A description of the procedure and management of the injuries is outlined.Results: In one case, a 3‐mm injury in the thyrohyoid membrane was identified. The TOETVA was converted to an open approach due to significant inflammation in the setting of Graves' and the repair was performed while open. In the second case, a fracture occurred from the thyroid notch to Broyle's ligament without avulsion. A primary repair was endoscopically performed.Conclusions: Airway injury is a possible complication of both open thyroidectomy and TOETVA. For TOETVA, trauma is most likely to occur in the midline during Hegar dilation and trocar placement through the central incision.


  • Transoral endoscopic vestibular approach Sistrunk procedure: First reported case series

    by Victoria E. Banuchi, Sallie M. Long, Bracha Y. Sachs, Julianna C. Kostas, Khalid M. Ali, Jonathon O. Russell

    Background: Standard of care for management of thyroglossal duct cysts (TGDCs) is a Sistrunk procedure performed through a transcervical incision. We describe the first series of Sistrunk procedures performed through a transoral endoscopic vestibular approach, eliminating a visible external scar.Methods: The transoral endoscopic vestibular approach to the Sistrunk (TEVAS) was performed in patients with TGDCs meeting inclusion criteria who desired a scarless approach.Results: Six patients (five females and one male) underwent TEVAS, with a mean age of 38 years (range 16–56 years) and a mean TGDC size of 1.8 cm (range 1.1–2.4 cm). Mean operative time was approximately 5 h (range 2–8 h). There were no surgical complications or recurrences.Conclusions: For appropriately selected patients, the TEVAS is an alternative to open neck surgery that provides improved cosmesis while maintaining successful resection outcomes. More data on outcomes including complications and recurrences are needed as additional case information is collected.


  • Open Access

    Transoral Endoscopic Vestibular Approach to the Sistrunk Procedure

    by Bracha Y. Sachs, Julianna C. Kostas, Sallie M. Long, Joshua Sturm, Jonathon O. Russell, Victoria E. Banuchi


  • Open Access

    Value within otolaryngology: Assessment of the cost‐utility analysis literature

    by Krupa R. Patel, David J. Phillips, Jason M. Leibowitz, Theresa Scognamiglio, Victoria E. Banuchi, William I. Kuhel, David I. Kutler, Marc A. Cohen

    To assess the characteristics and quality of cost utility analyses (CUA) related to otolaryngology within the CEA registry and to summarize their collective results. All cost-utility analyses published between 1976 and 2011 contained in the Cost-Effectiveness Analysis Registry (CEA Registry) were evaluated. Topics that fall within the care of an otolaryngologist were included in the review regardless of the presence of an otolaryngologist author. Potential associations between various study characteristics and CEA registry quality scores were evaluated using the Pearson product moment correlation coefficient. Sixty-one of 2913 (2.1%) total CUA publications screened were related to otolaryngology. Eighteen of 61 (29.5%) publications included an otolaryngologist as an author. Fourteen studies agreed on the cost effectiveness of at least unilateral cochlear implantation and six of seven (85.7%) studies demonstrated the cost effectiveness of continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA). Forty-six percent (28 of 61) of all manuscripts were published between 2008 and 2011. A more recent publication year was associated with a higher CEA registry quality score while the presence of an otolaryngologist author and journal impact factor had no significant correlation with the quality of the CUA. Based on current evidence in the CEA registry, unilateral cochlear implantation for hearing loss and CPAP for OSA are both cost-effective therapeutic interventions. Although CUAs in otolaryngology have increased in quantity and improved in quality in more recent years, there is a relative lack of CUAs in otolaryngology in comparison to other subspecialties.


  • Patterns of regional and distant metastasis in esthesioneuroblastoma

    by Victoria E. Banuchi, Laura Dooley, Nancy Y. Lee, David G. Pfister, Sean McBride, Nadeem Riaz, Mark H. Bilsky, Ian Ganly, Jatin P. Shah, Dennis H. Kraus, et al.

    Objectives/Hypothesis To define the incidence and risk factors of metastatic disease and the effectiveness of salvage therapy in esthesioneuroblastoma (ENB). Study Design Retrospective analysis of 57 patients presenting from 1979 through 2009. Methods Cumulative incidence of neck failure, distant failure, and survival were assessed using the Kaplan‐Meier method. Results Overall survival for all patients was 85% at 5 years and 75% at 10 years. Overall survival was negatively impacted by intracranial tumor extension (P < 0.001), positive resection margins (P = 0.05), and neck metastases (P = 0.017). Neck lymph nodes were not routinely electively irradiated during this time period. Nodal metastases developed in 17% of patients at a median time of 60 months. Kadish stage was not associated with a risk of nodal metastasis (P = 0.78). After treatment for nodal recurrence, locoregional control was achieved in 78% of patients. Of patients developing nodal recurrence, more than half developed distant metastases. The cumulative incidence of distant metastasis was 39% at a median time of 40 months. Patients who presented with Kadish stage C or D had a significantly increased risk of distant failure (P < 0.001). In patients developing nodal (P = 0.017) or distant metastasis (P = 0.001), the probability of survival was significantly decreased. Conclusion Regional and distant metastases in patients with esthesioneuroblastoma occur in a delayed fashion and negatively impact survival. Neck nodal recurrence may be a harbinger of distant metastases. At the Memorial Sloan Kettering Cancer Center, New York, New York, we now treat the majority of ENB patients with elective nodal irradiation. However, the chief obstacle to long‐term cure is distant metastases. Level of Evidence 4. Laryngoscope, 126:1556–1561, 2016


  • Cancers of the Nose, Sinus, and Skull Base

    by Victoria Banuchi, Jonathan Mallen, Dennis Kraus